id	sid	eid	entity	type
ijpds-3543	1	1	sonwani et al	PERSON
ijpds-3543	2	1	2	CARDINAL
ijpds-3543	2	2	2 | apr –	TIME
ijpds-3543	2	3	2023	CARDINAL
ijpds-3543	2	4	indian	NORP
ijpds-3543	2	5	j pharm drug	PRODUCT
ijpds-3543	2	6	69	CARDINAL
ijpds-3543	2	7	hari sonwani	PERSON
ijpds-3543	2	8	virendra kumar sharma	PERSON
ijpds-3543	2	9	steffi thomas	PERSON
ijpds-3543	2	10	kumar	PERSON
ijpds-3543	2	11	lnct university	ORG
ijpds-3543	3	1	m.p] india	ORG
ijpds-3543	4	1	hari sonwani	PERSON
ijpds-3543	4	2	lnct university	ORG
ijpds-3543	4	3	bhopal462042 madhya pradesh	ORG
ijpds-3543	4	4	india	GPE
ijpds-3543	6	1	1a	CARDINAL
ijpds-3543	8	1	2-p-(2-carboxyethyl	QUANTITY
ijpds-3543	8	2	phenethylamino-5'-n-ethylamino-5'-n-ethylamino-5'-nethylamino-5'-n	ORG
ijpds-3543	8	3	2	CARDINAL
ijpds-3543	8	4	1 200	CARDINAL
ijpds-3543	11	1	ib-meca	PERSON
ijpds-3543	12	1	ibmeca	PERSON
ijpds-3543	12	2	1 300	CARDINAL
ijpds-3543	13	1	mip-α	PERSON
ijpds-3543	14	1	0.5 mg/kg	QUANTITY
ijpds-3543	15	1	ib-meca	PERSON
ijpds-3543	15	2	nitrotyrosine	PERSON
ijpds-3543	16	1	ib-meca	PERSON
ijpds-3543	16	2	mip-α	ORG
ijpds-3543	18	1	a2a	GPE
ijpds-3543	18	2	a2b	GPE
ijpds-3543	18	3	polymorphonuclear leukocytes (pmns	ORG
ijpds-3543	18	4	1	CARDINAL
ijpds-3543	19	1	24.7	CARDINAL
ijpds-3543	20	1	lps	ORG
ijpds-3543	21	1	2	CARDINAL
ijpds-3543	23	1	mip-1 α	PERSON
ijpds-3543	23	2	3	CARDINAL
ijpds-3543	25	1	2	CARDINAL
ijpds-3543	25	2	2 | apr –	TIME
ijpds-3543	25	3	2023	CARDINAL
ijpds-3543	25	4	indian	NORP
ijpds-3543	25	5	j pharm drug	PRODUCT
ijpds-3543	25	6	70	CARDINAL
ijpds-3543	26	1	ib-meca	PERSON
ijpds-3543	27	1	mip-la	ORG
ijpds-3543	27	2	264.3	CARDINAL
ijpds-3543	27	3	24.7	CARDINAL
ijpds-3543	28	1	1 ml	QUANTITY
ijpds-3543	28	2	1300 mm	QUANTITY
ijpds-3543	28	3	2	CARDINAL
ijpds-3543	28	4	2-p-(2-carboxyethyl	QUANTITY
ijpds-3543	28	5	n-(3	ORG
ijpds-3543	29	1	research biochemicals inc.	ORG
ijpds-3543	30	1	30 minutes	TIME
ijpds-3543	30	2	lps	ORG
ijpds-3543	30	3	1–3 hours later	TIME
ijpds-3543	31	1	1	CARDINAL
ijpds-3543	31	2	50	CARDINAL
ijpds-3543	31	3	second	ORDINAL
ijpds-3543	32	1	mip-1α	PERSON
ijpds-3543	33	1	1.5	CARDINAL
ijpds-3543	34	1	trizol	GPE
ijpds-3543	35	1	1%	PERCENT
ijpds-3543	35	2	15	CARDINAL
ijpds-3543	36	1	92 percent	PERCENT
ijpds-3543	36	2	two	CARDINAL
ijpds-3543	37	1	32p	CARDINAL
ijpds-3543	37	2	3,000	CARDINAL
ijpds-3543	39	1	42°	QUANTITY
ijpds-3543	39	2	1 hour	TIME
ijpds-3543	39	3	1.5107	CARDINAL
ijpds-3543	40	1	53°	QUANTITY
ijpds-3543	40	2	2	CARDINAL
ijpds-3543	40	3	0.1 percent	PERCENT
ijpds-3543	41	1	70°	QUANTITY
ijpds-3543	42	1	5 mm	QUANTITY
ijpds-3543	42	2	18s	CARDINAL
ijpds-3543	42	3	mip-1α	PERSON
ijpds-3543	43	1	264.3	CARDINAL
ijpds-3543	43	2	ib meca	PERSON
ijpds-3543	44	1	ib-meca	PERSON
ijpds-3543	44	2	il12	PRODUCT
ijpds-3543	44	3	24.7	CARDINAL
ijpds-3543	45	1	1 300	QUANTITY
ijpds-3543	45	2	mib-meca	ORG
ijpds-3543	46	1	30 minutes	TIME
ijpds-3543	46	2	lps	ORG
ijpds-3543	46	3	10	CARDINAL
ijpds-3543	46	4	ifn(200	GPE
ijpds-3543	46	5	u ml—1	PERSON
ijpds-3543	46	6	genzyme	ORG
ijpds-3543	46	7	boston	GPE
ijpds-3543	46	8	ma, usa	ORG
ijpds-3543	49	1	lps	ORG
ijpds-3543	50	1	24-hour	TIME
ijpds-3543	50	2	37°	QUANTITY
ijpds-3543	50	3	70°	QUANTITY
ijpds-3543	52	1	ila	ORG
ijpds-3543	52	2	250	CARDINAL
ijpds-3543	52	3	450	CARDINAL
ijpds-3543	53	1	10 pg ml—1	MONEY
ijpds-3543	53	2	5 pg ml—1	PERCENT
ijpds-3543	53	3	5	CARDINAL
ijpds-3543	55	1	4°	QUANTITY
ijpds-3543	55	2	overnight	TIME
ijpds-3543	56	1	cii	ORG
ijpds-3543	56	2	70°	QUANTITY
ijpds-3543	57	1	2 mg ml—1	QUANTITY
ijpds-3543	57	2	freund	ORG
ijpds-3543	57	3	cfa	ORG
ijpds-3543	58	1	cii	ORG
ijpds-3543	58	2	cfa	ORG
ijpds-3543	59	1	1998	DATE
ijpds-3543	60	1	day 1	DATE
ijpds-3543	60	2	100	CARDINAL
ijpds-3543	60	3	100	CARDINAL
ijpds-3543	61	1	second	ORDINAL
ijpds-3543	61	2	cii	ORG
ijpds-3543	61	3	cfa	ORG
ijpds-3543	61	4	day 21	DATE
ijpds-3543	62	1	0.5	CARDINAL
ijpds-3543	63	1	al.	PERSON
ijpds-3543	63	2	1997	DATE
ijpds-3543	63	3	tracey et al.	PERSON
ijpds-3543	63	4	1994	DATE
ijpds-3543	63	5	tracey et al.	PERSON
ijpds-3543	63	6	1997	DATE
ijpds-3543	64	1	day 18	DATE
ijpds-3543	64	2	ib meca	PERSON
ijpds-3543	64	3	n=18	ORG
ijpds-3543	64	4	0.5	CARDINAL
ijpds-3543	64	5	kg—1	GPE
ijpds-3543	64	6	i.p.	GPE
ijpds-3543	65	1	every 24 hours	TIME
ijpds-3543	66	1	daily	DATE
ijpds-3543	67	1	0 to	PERCENT
ijpds-3543	67	2	4	CARDINAL
ijpds-3543	67	3	0	CARDINAL
ijpds-3543	67	4	1	CARDINAL
ijpds-3543	67	5	one	CARDINAL
ijpds-3543	67	6	2	CARDINAL
ijpds-3543	67	7	two	CARDINAL
ijpds-3543	67	8	3	CARDINAL
ijpds-3543	67	9	more than two	CARDINAL
ijpds-3543	67	10	4	CARDINAL
ijpds-3543	68	1	four	CARDINAL
ijpds-3543	70	1	nitrotyrosine immunohistochemistry	PERSON
ijpds-3543	70	2	day 35	DATE
ijpds-3543	71	1	nitrotyrosine immunohistochemistry	ORG
ijpds-3543	74	1	immunohistochemistry	ORG
ijpds-3543	74	2	15 minutes	TIME
ijpds-3543	74	3	0.3	CARDINAL
ijpds-3543	75	1	2	CARDINAL
ijpds-3543	75	2	2 | apr –	TIME
ijpds-3543	75	3	2023	CARDINAL
ijpds-3543	75	4	indian	NORP
ijpds-3543	75	5	j pharm drug	PRODUCT
ijpds-3543	75	6	71 percent	PERCENT
ijpds-3543	75	7	pbs	ORG
ijpds-3543	76	1	2 percent	PERCENT
ijpds-3543	76	2	0 minutes	TIME
ijpds-3543	77	1	1	CARDINAL
ijpds-3543	77	2	500	CARDINAL
ijpds-3543	79	1	10 mm nitrotyrosine	QUANTITY
ijpds-3543	81	1	nitrotyrosine	PERSON
ijpds-3543	81	2	35 days	DATE
ijpds-3543	81	3	10	CARDINAL
ijpds-3543	81	4	20	CARDINAL
ijpds-3543	81	5	10	CARDINAL
ijpds-3543	81	6	1 mm	QUANTITY
ijpds-3543	81	7	7.25	CARDINAL
ijpds-3543	81	8	il12	PRODUCT
ijpds-3543	81	9	thirty gram	QUANTITY
ijpds-3543	81	10	95°	QUANTITY
ijpds-3543	81	11	3 minutes	TIME
ijpds-3543	82	1	1%	PERCENT
ijpds-3543	83	1	2 hours	TIME
ijpds-3543	83	2	120 volts	QUANTITY
ijpds-3543	83	3	0.45	CARDINAL
ijpds-3543	83	4	30 volts	QUANTITY
ijpds-3543	83	5	0 minutes	TIME
ijpds-3543	83	6	1/2towbin	CARDINAL
ijpds-3543	83	7	1.45	CARDINAL
ijpds-3543	83	8	7.2 g	QUANTITY
ijpds-3543	83	9	800 ml	QUANTITY
ijpds-3543	83	10	200 ml	QUANTITY
ijpds-3543	84	1	1 percent	PERCENT
ijpds-3543	84	2	bsa	ORG
ijpds-3543	84	3	1 percent	PERCENT
ijpds-3543	84	4	pbs	ORG
ijpds-3543	84	5	0.05 percent	PERCENT
ijpds-3543	84	6	20	CARDINAL
ijpds-3543	84	7	1 hour	TIME
ijpds-3543	84	8	1	CARDINAL
ijpds-3543	84	9	overnight	TIME
ijpds-3543	84	10	4°	QUANTITY
ijpds-3543	85	1	three	CARDINAL
ijpds-3543	85	2	pbs	ORG
ijpds-3543	85	3	1.5 hours	TIME
ijpds-3543	85	4	1	CARDINAL
ijpds-3543	85	5	3000	CARDINAL
ijpds-3543	86	1	three	CARDINAL
ijpds-3543	86	2	pbs	ORG
ijpds-3543	86	3	1.5 ml	QUANTITY
ijpds-3543	86	4	1 minute	TIME
ijpds-3543	87	1	0 seconds	TIME
ijpds-3543	88	1	0.5 percent	PERCENT
ijpds-3543	88	2	10 mm	QUANTITY
ijpds-3543	88	3	20,000	CARDINAL
ijpds-3543	88	4	30 minutes	TIME
ijpds-3543	88	5	4°	QUANTITY
ijpds-3543	89	1	1. mm	QUANTITY
ijpds-3543	89	2	0.1 mm	QUANTITY
ijpds-3543	90	1	50	CARDINAL
ijpds-3543	92	1	1	CARDINAL
ijpds-3543	92	2	37°	QUANTITY
ijpds-3543	93	1	9	CARDINAL
ijpds-3543	93	2	two to three	CARDINAL
ijpds-3543	94	1	two	CARDINAL
ijpds-3543	94	2	dunnett	GPE
ijpds-3543	95	1	2	CARDINAL
ijpds-3543	96	1	less than 0.05	CARDINAL
ijpds-3543	97	1	mip-l	ORG
ijpds-3543	97	2	lps	ORG
ijpds-3543	97	3	10 ng/ml	QUANTITY
ijpds-3543	98	1	ib-meca	PERSON
ijpds-3543	98	2	cgs-2180	DATE
ijpds-3543	98	3	1	CARDINAL
ijpds-3543	99	1	200	CARDINAL
ijpds-3543	99	2	213 percent	PERCENT
ijpds-3543	100	1	mtt	ORG
ijpds-3543	102	1	50	CARDINAL
ijpds-3543	102	2	245%	PERCENT
ijpds-3543	102	3	200	CARDINAL
ijpds-3543	102	4	ib-meca	PERSON
ijpds-3543	102	5	2	CARDINAL
ijpds-3543	103	1	a2	ORG
ijpds-3543	103	2	2	CARDINAL
ijpds-3543	106	1	200	CARDINAL
ijpds-3543	106	2	roughly 50%	PERCENT
ijpds-3543	106	3	nearly 50%	PERCENT
ijpds-3543	106	4	1	CARDINAL
ijpds-3543	106	5	lps	ORG
ijpds-3543	106	6	3 hours	TIME
ijpds-3543	106	7	lps	ORG
ijpds-3543	106	8	2 hours	TIME
ijpds-3543	106	9	lps	ORG
ijpds-3543	106	10	two	CARDINAL
ijpds-3543	108	1	ib-meca	PERSON
ijpds-3543	110	1	lps	ORG
ijpds-3543	110	2	10	CARDINAL
ijpds-3543	110	3	ifn(200	GPE
ijpds-3543	110	4	u ml—1	PERSON
ijpds-3543	110	5	2	CARDINAL
ijpds-3543	110	6	2 | apr –	TIME
ijpds-3543	110	7	2023	CARDINAL
ijpds-3543	110	8	indian	NORP
ijpds-3543	110	9	j pharm drug	PRODUCT
ijpds-3543	110	10	72	CARDINAL
ijpds-3543	110	11	24.7	CARDINAL
ijpds-3543	110	12	24-hour	TIME
ijpds-3543	110	13	lps	ORG
ijpds-3543	110	14	10	CARDINAL
ijpds-3543	110	15	ifn(200	GPE
ijpds-3543	110	16	u ml—1	PERSON
ijpds-3543	110	17	4a	CARDINAL
ijpds-3543	111	1	30 minutes	TIME
ijpds-3543	111	2	lps +	ORG
ijpds-3543	111	3	24 hours	TIME
ijpds-3543	111	4	4a	CARDINAL
ijpds-3543	112	1	24 hours	TIME
ijpds-3543	112	2	lps	ORG
ijpds-3543	112	3	10	CARDINAL
ijpds-3543	112	4	24.7	CARDINAL
ijpds-3543	113	1	ib-meca	PERSON
ijpds-3543	113	2	30 minutes	TIME
ijpds-3543	113	3	lps	ORG
ijpds-3543	113	4	4b	CARDINAL
ijpds-3543	114	1	ib-meca	PERSON
ijpds-3543	114	2	mtt	ORG
ijpds-3543	115	1	ibstronger meca's	PERSON
ijpds-3543	115	2	two	CARDINAL
ijpds-3543	117	1	ib-meca	PERSON
ijpds-3543	117	2	between days 2 and 35	DATE
ijpds-3543	117	3	first	ORDINAL
ijpds-3543	117	4	ib-meca	PERSON
ijpds-3543	117	5	0.5 mg/kg	QUANTITY
ijpds-3543	117	6	i.p.	PERSON
ijpds-3543	119	1	day 35	DATE
ijpds-3543	121	1	991 mu/mg	QUANTITY
ijpds-3543	122	1	ib-meca	PERSON
ijpds-3543	123	1	3 mu/mg	QUANTITY
ijpds-3543	123	2	n=12	ORG
ijpds-3543	124	1	35 days	DATE
ijpds-3543	124	2	il12 p70	GPE
ijpds-3543	125	1	il12	PRODUCT
ijpds-3543	125	2	7	CARDINAL
ijpds-3543	127	1	3	CARDINAL
ijpds-3543	127	2	4 & 5	DATE
ijpds-3543	128	1	1	CARDINAL
ijpds-3543	129	1	a2	ORG
ijpds-3543	129	2	10 ng ml—1	QUANTITY
ijpds-3543	130	1	0.5	CARDINAL
ijpds-3543	130	2	5	DATE
ijpds-3543	130	3	50	DATE
ijpds-3543	130	4	100 μm ib-meca	QUANTITY
ijpds-3543	130	5	3	CARDINAL
ijpds-3543	131	1	ib-meca	PERSON
ijpds-3543	131	2	200 μm	QUANTITY
ijpds-3543	131	3	3	CARDINAL
ijpds-3543	132	1	4	CARDINAL
ijpds-3543	132	2	18s mrna	TIME
ijpds-3543	134	1	2	CARDINAL
ijpds-3543	135	1	a2	ORG
ijpds-3543	135	2	3	CARDINAL
ijpds-3543	135	3	10 ng ml—1	QUANTITY
ijpds-3543	136	1	ng ml—1	PERSON
ijpds-3543	136	2	100%	PERCENT
ijpds-3543	138	1	9	CARDINAL
ijpds-3543	138	2	two to three	CARDINAL
ijpds-3543	139	1	sonwani et al	PERSON
ijpds-3543	139	2	2	CARDINAL
ijpds-3543	139	3	2 | apr –	TIME
ijpds-3543	139	4	2023	CARDINAL
ijpds-3543	139	5	indian	NORP
ijpds-3543	139	6	j pharm drug	PRODUCT
ijpds-3543	139	7	73	CARDINAL
ijpds-3543	139	8	3	CARDINAL
ijpds-3543	140	1	1	CARDINAL
ijpds-3543	141	1	ib-meca	PERSON
ijpds-3543	143	1	n=10	PERSON
ijpds-3543	143	2	12	CARDINAL
ijpds-3543	144	1	day 28	DATE
ijpds-3543	144	2	ib-meca	PERSON
ijpds-3543	144	3	day 30	DATE
ijpds-3543	144	4	¢p<0.05	PERSON
ijpds-3543	145	1	4	CARDINAL
ijpds-3543	146	1	lps	ORG
ijpds-3543	146	2	10 μg ml—1	MONEY
ijpds-3543	146	3	200 mu/ml	QUANTITY
ijpds-3543	146	4	24	CARDINAL
ijpds-3543	146	5	lps	ORG
ijpds-3543	146	6	10 μg ml—1	MONEY
ijpds-3543	146	7	24	CARDINAL
ijpds-3543	146	8	lps	ORG
ijpds-3543	146	9	10 ng/ml	QUANTITY
ijpds-3543	146	10	ifn-ц(200 mu ml—1	PERSON
ijpds-3543	146	11	3	CARDINAL
ijpds-3543	146	12	378±23	CARDINAL
ijpds-3543	146	13	ng ml—1	PERSON
ijpds-3543	146	14	49±5 μm	QUANTITY
ijpds-3543	146	15	100%	PERCENT
ijpds-3543	148	1	9	CARDINAL
ijpds-3543	148	2	two to three	CARDINAL
ijpds-3543	149	1	ib-meca	PERSON
ijpds-3543	150	1	5	CARDINAL
ijpds-3543	151	1	35 days	DATE
ijpds-3543	151	2	ib-meca	PERSON
ijpds-3543	151	3	35 days	DATE
ijpds-3543	152	1	n=10	PERSON
ijpds-3543	152	2	12	CARDINAL
ijpds-3543	155	1	martin	PERSON
ijpds-3543	155	2	dorf	ORG
ijpds-3543	155	3	1991	DATE
ijpds-3543	156	1	3-5	CARDINAL
ijpds-3543	158	1	6	CARDINAL
ijpds-3543	161	1	7	CARDINAL
ijpds-3543	162	1	ib-meca	PERSON
ijpds-3543	163	1	9	CARDINAL
ijpds-3543	163	2	10	CARDINAL
ijpds-3543	164	1	ib-meca	PERSON
ijpds-3543	165	1	2	CARDINAL
ijpds-3543	165	2	2 | apr –	TIME
ijpds-3543	165	3	2023	CARDINAL
ijpds-3543	165	4	indian	NORP
ijpds-3543	165	5	j pharm drug	PRODUCT
ijpds-3543	165	6	74	CARDINAL
ijpds-3543	167	1	24.7	CARDINAL
ijpds-3543	168	1	11	CARDINAL
ijpds-3543	169	1	monocytes/	ORG
ijpds-3543	170	1	12	CARDINAL
ijpds-3543	172	1	cii	ORG
ijpds-3543	172	2	freund	ORG
ijpds-3543	172	3	15	CARDINAL
ijpds-3543	173	1	cii	ORG
ijpds-3543	173	2	cfa	ORG
ijpds-3543	174	1	13	CARDINAL
ijpds-3543	178	1	14	CARDINAL
ijpds-3543	180	1	17-20	CARDINAL
ijpds-3543	181	1	mip-1α production.by	ORG
ijpds-3543	186	1	1	CARDINAL
ijpds-3543	186	2	kunkel sl	PERSON
ijpds-3543	186	3	lukacs nw	PERSON
ijpds-3543	188	1	j immunol	PERSON
ijpds-3543	190	1	1995	DATE
ijpds-3543	191	1	2023	CARDINAL
ijpds-3543	192	1	2	CARDINAL
ijpds-3543	192	2	szabó c, lim lh	PERSON
ijpds-3543	192	3	cuzzocrea s	PERSON
ijpds-3543	194	1	1997	DATE
ijpds-3543	194	2	2023	CARDINAL
ijpds-3543	195	1	3	CARDINAL
ijpds-3543	195	2	tracey wr	PERSON
ijpds-3543	195	3	magee w	PERSON
ijpds-3543	195	4	masamune	PERSON
ijpds-3543	196	1	cardiovasc	ORG
ijpds-3543	197	1	1997	DATE
ijpds-3543	198	1	2023	CARDINAL
ijpds-3543	199	1	4	CARDINAL
ijpds-3543	199	2	lin rc-s	PERSON
ijpds-3543	199	3	popik p	ORG
ijpds-3543	202	1	1994;263(1–2):59–67	CARDINAL
ijpds-3543	202	2	5	CARDINAL
ijpds-3543	202	3	wolberg g	PERSON
ijpds-3543	202	4	zimmerman tp	PERSON
ijpds-3543	203	1	ann n y acad sci	PERSON
ijpds-3543	205	1	1985;451(1):215–26	CARDINAL
ijpds-3543	206	1	6	CARDINAL
ijpds-3543	206	2	al-mughales j	PERSON
ijpds-3543	206	3	blyth th	PERSON
ijpds-3543	206	4	hunter ja	PERSON
ijpds-3543	208	1	clin	PERSON
ijpds-3543	210	1	1996;106(2):230–6.	DATE
ijpds-3543	211	1	7	CARDINAL
ijpds-3543	211	2	auchampach ja	PERSON
ijpds-3543	211	3	qiu y	PERSON
ijpds-3543	211	4	3	CARDINAL
ijpds-3543	211	5	6	CARDINAL
ijpds-3543	215	1	8	CARDINAL
ijpds-3543	216	1	koppenol	PERSON
ijpds-3543	216	2	j physiol	PERSON
ijpds-3543	218	1	1996;271(5):c1424–37	CARDINAL
ijpds-3543	219	1	9	CARDINAL
ijpds-3543	220	1	sheth s	PERSON
ijpds-3543	220	2	brito r	PERSON
ijpds-3543	221	1	j mol sci	PERSON
ijpds-3543	223	1	2014;15(2):2024–52	CARDINAL
ijpds-3543	224	1	10	CARDINAL
ijpds-3543	224	2	connor jr, manning pt	PERSON
ijpds-3543	225	1	eur	CARDINAL
ijpds-3543	228	1	11	CARDINAL
ijpds-3543	229	1	haskó g	PERSON
ijpds-3543	232	1	2013;4:85	CARDINAL
ijpds-3543	233	1	12	CARDINAL
ijpds-3543	234	1	eberle ma	PERSON
ijpds-3543	236	1	1991;88(6):2441–5	CARDINAL
ijpds-3543	236	2	13	CARDINAL
ijpds-3543	236	3	ostad e.	PERSON
ijpds-3543	237	1	sonwani et al	PERSON
ijpds-3543	238	1	2	CARDINAL
ijpds-3543	238	2	2 | apr –	TIME
ijpds-3543	238	3	2023	CARDINAL
ijpds-3543	238	4	indian	NORP
ijpds-3543	238	5	j pharm drug	PRODUCT
ijpds-3543	238	6	75	CARDINAL
ijpds-3543	239	1	j clin	PERSON
ijpds-3543	241	1	1993;92(6):2675–82	CARDINAL
ijpds-3543	242	1	14	CARDINAL
ijpds-3543	244	1	j physiol	PERSON
ijpds-3543	246	1	1993;265(3):c577–606	CARDINAL
ijpds-3543	247	1	15	CARDINAL
ijpds-3543	247	2	eiserich jp	PERSON
ijpds-3543	247	3	hristova m	ORG
ijpds-3543	250	1	1998;391(6665):393–7	CARDINAL
ijpds-3543	251	1	16	CARDINAL
ijpds-3543	252	1	gadangi p	PERSON
ijpds-3543	254	1	j immunol	PERSON
ijpds-3543	255	1	1996	DATE
ijpds-3543	256	1	2023	CARDINAL
ijpds-3543	256	2	10];156(5):1937–41	DATE
ijpds-3543	257	1	17	CARDINAL
ijpds-3543	258	1	gallo-rodriguez c	ORG
ijpds-3543	258	2	n6-benzyladenosine-5’-uronamides	MONEY
ijpds-3543	261	1	1994;37(5):636–46	CARDINAL
ijpds-3543	261	2	18	CARDINAL
ijpds-3543	262	1	halliwell b.	PERSON
ijpds-3543	263	1	nitrotyrosine	PERSON
ijpds-3543	264	1	lett	PERSON
ijpds-3543	266	1	1997;411(2–3):157–60.	DATE
ijpds-3543	267	1	haskó g	PERSON
ijpds-3543	267	2	szabó	PERSON
ijpds-3543	267	3	németh zh	PERSON
ijpds-3543	267	4	264.7	CARDINAL
ijpds-3543	268	1	j immunol	PERSON
ijpds-3543	269	1	1996	DATE
ijpds-3543	270	1	2023	CARDINAL
ijpds-3543	270	2	20	CARDINAL
ijpds-3543	271	1	haskó g	PERSON
ijpds-3543	271	2	szabó	PERSON
ijpds-3543	271	3	németh zh	PERSON
ijpds-3543	272	1	j immunol	PERSON
ijpds-3543	274	1	1998	DATE
ijpds-3543	275	1	2023	CARDINAL
ijpds-3543	276	1	hari sonwani	PERSON
ijpds-3543	276	2	virendra kumar sharma	PERSON
ijpds-3543	276	3	steffi thomas	PERSON
ijpds-3543	276	4	kumar	PERSON
ijpds-3543	278	1	indian	NORP
ijpds-3543	279	1	2023	CARDINAL
ijpds-3543	279	2	2(2	CARDINAL
ijpds-3543	279	3	69	CARDINAL